SEC Form 4/A · accession 0000899243-17-018659

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

Director

Period of report

Jul 12, 2017

Accepted (ET)

Jul 20, 2017 · 9:04 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001088856

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 12, 2017	M	6,510	$2.23	A	1,142,183	I	Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust
Common Stock	Jul 12, 2017	S	6,510	$12.50	D	1,135,673	I	Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust
Common Stock	Jul 13, 2017	M	484	$2.23	A	1,136,157	I	Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust
Common Stock^F2	Jul 13, 2017	S	484	$12.548	D	1,135,673	I	Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$2.23	Jul 12, 2017	M	6,510	D	—	Jun 9, 2018	Common Stock	6,510	23,490	D
Stock Option (Right to Buy)^F3	$2.23	Jul 13, 2017	M	484	D	—	Jun 9, 2018	Common Stock	484	23,006	D

F1These transactions are made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.
F2Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $12.52 to $12.56 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F3Fully exercisable.